Table VI.

Twenty-three miRNAs expressed only in the N- group, 15 miRNAs expressed only in the N+ group. Red: overexpression with respect to healthy control tissue from the patients with LSCC; blue: downregulation with respect to healthy control tissues from the patients with LSCC; n.e.c.: no expression change.

N-	Fold change	N+	Fold change
hsa-miR-146b-3p	1879	hsa-miR-190	0787
hsa-miR-148b	2455	hsa-miR-486-3p	0047
hsa-miR-338-3p	1043	hsa-miR-542-5p	2795
hsa-miR-339-5p	0359	hsa-miR-618	13980
hsa-miR-485-3p	2172	hsa-miR-198	n.e.c.
hsa-miR-518b	0829	hsa-miR-342 5p	n.e.c.
hsa-miR-518f	0509	hsa-miR-369 3p	n.e.c.
hsa-miR-627	0827	hsa-miR-373	n.e.c.
hsa-miR-216b	n.e.c.	hsa-miR-433	n.e.c.
hsa-miR-296	n.e.c.	hsa-miR-450b 5p	n.e.c.
hsa-miR-323 3p	n.e.c.	hsa-miR-487b	n.e.c.
hsa-miR-372	n.e.c.	hsa-miR-545	n.e.c.
hsa-miR-382	n.e.c.	hsa-miR-597	n.e.c.
hsa-miR-503	n.e.c.	hsa-miR-876 3p	n.e.c.
hsa-miR-518c	n.e.c.	hsa-miR-876 5p	n.e.c.
hsa-miR-529a	n.e.c.
hsa-miR-522	n.e.c.
hsa-miR-548d	n.e.c.
hsa-miR-582 5p	n.e.c.
hsa-miR-636	n.e.c.
hsa-miR-651	n.e.c.
hsa-miR-873	n.e.c.
hsa-miR-137	n.e.c.